201. Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease
- Author
-
Murray, Iain A., Daniels, Ian, Coupland, Kathryn, Smith, Julie A., and Long, Richard G.
- Subjects
Nitric oxide -- Physiological aspects ,Celiac disease -- Physiological aspects ,Intestinal absorption -- Physiological aspects ,Biological sciences - Abstract
The activity of nitric oxide synthase (NOS) was assayed in enterocytes isolated from human duodenal biopsies to determine its role in celiac disease. Patients were categorized into groups with irritable bowel syndrome, iron-deficiency anemia, [B.sub.12]/folate deficiency, and treated and untreated celiac disease. Enterocytes isolated from all groups showed 1400W-inhibitable [Ca.sup.2+]-independent NOS activity with a pH level and temperature optimum of 9.4 and 37[degrees]C, respectively. Western blotting showed that enterocytes expressed the inducible NOS protein and proteins with nitrated tyrosine residues, the latter being indicative of nitric oxide-driven peroxynitrite and/or free-radical damage. Endothelial NOS was seen only in the lamina propria. Patients with celiac disease had higher NOS activity than other patient groups. Treatment of the condition led to a fall in activity. Enzyme-linked immunosorbent assay demonstrated cGMP production by the enterocyte fraction, but cGMP levels did not correlate with NOS activity. These results suggest that inducible NOS is constitutively expressed in human duodenal enterocytes, is increased in patients with untreated celiac disease, and is partially corrected when such patients are treated. We found no evidence to support a role for nitric oxide in the formation of cGMP within the small intestine. Furthermore, we were unable to demonstrate a role for peroxynitrite/free radical damage in the pathophysiology of celiac disease. small bowel; malabsorption; nitric oxide; peroxynitrite; guanosine 3',5'-cyclic monophosphate
- Published
- 2002